The Optimal Intraoperative Supplemental Oxygen Administration During Minimally Invasive Esophagectomy
- Conditions
- Oxygenation Index
- Registration Number
- NCT02026739
- Lead Sponsor
- Tan, Lijie
- Brief Summary
The study hypothesized that a relative low oxygen concentration (40%) supplemental would be advantageous to protect the pulmonary function of patients, comparied with conventional high oxygen concentration (80%). Therefore we raise this prospective randomized controlled research.
- Detailed Description
Patients underwent minimally invasive esophagectomy in Zhongshan Hospital of Fudan University will be enrolled and be randomizedly assigned to low oxygen concentration (40%) supplemental or high oxygen concentration(80%) supplemental group. Intra-operative and post-operative pressure of Oxygen in Arterial Blood will be examined, and the surgical outcome will be recorded in the two groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as T1-3N0M0 esophageal cancer after neo-adjuvant therapy.
- Patients underwent minimally invasive esophagectomy(Thoracolaparoscopic McKeown procedure).
- Patients with previous thoracic surgery history.
- Patients with severe Co-morbidity.
- Pulmonary function is abnormal in the examination before surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method The change of oxygenation index Change from Baseline at post-operative Day1 The change of oxygenation index is an important index to indicate the pulmonary function of patients.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Division of Thoracic Surgery & Anesthesiology, Zhongshan Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Division of Thoracic Surgery & Anesthesiology, Zhongshan Hospital of Fudan University🇨🇳Shanghai, Shanghai, ChinaHao Wang, MDContactwang.hao@zs-hospital.sh.cnFang Fang, MDSub InvestigatorJing Cang, MDPrincipal Investigator